Sanofi Earnings Boosted by Early Vaccine Sales

The pharmaceutical company reported third-quarter earnings and sales that beat analysts’ expectations, boosted by earlier-than-anticipated deliveries of flu and respiratory syncytial virus vaccines and growing demand for blockbuster anti-inflammatory drug Dupixent.

Read more at The Wall Street Journal

Save story

Topics

Related

Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
Business - CNBC - October 31
Volvo Global Sales Boosted by EVs
Business - The Wall Street Journal - November 4
GSK cuts vaccine sales target on reduced demand
Business - MarketWatch - October 30
Kuehne + Nagel Earnings Boosted by Volume Growth and Efficiencies
Business - The Wall Street Journal - October 23
Google’s strong earnings boosted by cloud computing gains
Business - Financial Times - October 30
The Key to Boosting Sales: Identifying and Converting Non-Customers
Business - Inc. - October 26
How Amazon Sellers Can Boost Their Holiday Sales
Business - Inc. - October 28
8 Strategies to Boost Black Friday Sales
Business - Inc. - November 9

More from The Wall Street Journal

Boohoo Changes Chairman as Frasers Calls For Removal
Business - The Wall Street Journal - 3 hours ago
Resolute Mining Says CEO, Employees Released From Detention in Mali
Business - The Wall Street Journal - 4 hours ago
JD Sports Expects Profit at Lower End of Guidance
Business - The Wall Street Journal - 5 hours ago
Novartis Lifts Sales Outlook on Key Drugs, Pipeline Portfolio
Business - The Wall Street Journal - 5 hours ago
Julius Baer Assets Rise as Inflows Accelerate
Business - The Wall Street Journal - 5 hours ago